Hormone optimization for men over 50 is not the same as testosterone replacement therapy for a 35-year-old. The hormonal landscape shifts, the risks change, and the monitoring requirements become more specific. This guide covers what a clinician evaluates, treats, and tracks for men over 50 pursuing hormone optimization in 2026.
- Hormone optimization at 50+ requires a full panel — total and free testosterone, estradiol, DHT, SHBG, LH, FSH, PSA, hematocrit, lipid panel, and fasting insulin — not just a testosterone draw.
- Rising SHBG after 50 means total testosterone can look normal while free (bioavailable) testosterone is low.
- Insulin resistance is the most common reversible cause of low testosterone in this age group and should be addressed before or alongside TRT.
- PSA and a digital prostate exam are mandatory before starting TRT, with urology referral if PSA exceeds 2.5 ng/mL.
- Hematocrit above 54% and PSA above 4.0 ng/mL are the two safety thresholds that drive dose changes most often.
- A structured recheck schedule — 6 weeks, 3 months, 6 months, then every 6-12 months — is the backbone of safe optimization.
TL;DR
Hormone optimization for men over 50 starts with a full panel — total and free testosterone, estradiol, DHT, SHBG, LH, FSH, PSA, hematocrit, lipid panel, and fasting insulin — not just a testosterone draw. Men over 50 have higher SHBG, which means total testosterone can look acceptable while free (bioavailable) testosterone is low. Verdict: optimizing hormones at 50+ is viable and well-studied, but it requires more monitoring than at 35 — prostate health, hematocrit, and cardiovascular markers all matter more. A clinician who structures the protocol around your age-specific risk profile gets better outcomes than one who applies a one-size protocol.
Why This Matters
After 50, three things change simultaneously: testosterone production declines (roughly 1% per year accelerates), SHBG rises (binding more testosterone and reducing the free fraction), and prostate cancer risk increases (making PSA monitoring non-optional). At the same time, many men over 50 are on medications for blood pressure, cholesterol, or glucose — each of which can interact with hormone therapy.
This means hormone optimization at 50+ is not simply "raise testosterone." It's a multi-marker protocol that balances testosterone, estrogen, metabolic health, and prostate safety in a man whose baseline risks are different from a 35-year-old's.
What You'll Need
- Two morning (7-9 AM) total testosterone draws, 2-4 weeks apart
- Free testosterone or calculated free testosterone (critical for men over 50 — SHBG is often elevated)
- SHBG level (to calculate bioavailable testosterone)
- Estradiol (testosterone aromatizes to estrogen, and estrogen management matters more at 50+)
- LH and FSH (to identify whether low testosterone is primary or secondary)
- PSA and digital prostate exam (mandatory before starting TRT at any age over 40)
- Hematocrit and hemoglobin (TRT increases red blood cell production, and baseline is often already higher in men over 50)
- Lipid panel (TRT can shift lipid profiles)
- Fasting insulin and HbA1c (insulin resistance is the most common confounder of low testosterone in this age group)
- A clinician who will re-test at 6 weeks, 3 months, and 6 months — and who understands the age-specific monitoring requirements
The Steps
1. Get the full panel, not just testosterone
Total testosterone alone misses the picture for men over 50 because SHBG rises with age, binding more testosterone and leaving less free hormone available. A man with total testosterone of 400 ng/dL but SHBG of 60 nmol/L has significantly less bioavailable testosterone than a 35-year-old with the same total. Free testosterone is the number that correlates with symptoms. Common mistake: accepting a "normal" total testosterone result without checking free testosterone and SHBG.
Free testosterone is the number that correlates with symptoms — a "normal" total testosterone result means little in a man over 50 if free testosterone and SHBG haven't been checked.
2. Address insulin resistance first if it's present
Insulin resistance suppresses testosterone production and raises SHBG — it's the single most common reversible cause of low testosterone in men over 50 who carry excess abdominal weight. Fasting insulin above 10 uIU/mL or HbA1c above 5.7% suggests insulin resistance. Weight loss of 5-10% of body weight can raise free testosterone by 20-30% without any hormone therapy. A clinician should evaluate whether metabolic intervention can improve the hormonal picture before starting TRT. Common mistake: starting TRT without addressing the metabolic driver, which means you're treating a symptom while the cause continues.
3. Get prostate clearance before starting
PSA should be checked at baseline, and a digital rectal exam should be performed by a clinician. If PSA is above 2.5 ng/mL in a man over 50, a urology referral is warranted before starting TRT — not because TRT causes prostate cancer, but because it can accelerate an existing cancer. Common mistake: skipping the prostate evaluation because the patient feels healthy. Prostate cancer in early stages is asymptomatic.
TRT does not initiate prostate cancer, but it can accelerate an existing cancer.
4. Start with a conservative dose
For men over 50, starting at the lower end of the TRT dosing range (75-100 mg testosterone cypionate weekly, or 150 mg every 10 days) is safer than starting high. The goal is to bring free testosterone into the mid-normal range (typically 100-150 pg/mL), not to the top of the range. Higher starting doses risk estrogen conversion, hematocrit elevation, and prostate marker changes that require immediate dose reduction. Common mistake: starting at a bodybuilder dose and dealing with side effects instead of titrating up slowly.
5. Monitor hematocrit closely
Men over 50 already have higher baseline hematocrit. TRT raises it further. If hematocrit exceeds 54%, the dose must be reduced or the injection interval shortened. Persistent elevation may require therapeutic phlebotomy (donating blood). This is the single most common reason men over 50 need dose adjustments in the first 6 months. Common mistake: not checking hematocrit until symptoms (headaches, dizziness, flush skin) appear — these are late signs of significant elevation.
6. Monitor estradiol and DHT
Testosterone converts to estradiol (via aromatase) and DHT (via 5-alpha reductase). In men over 50, elevated estradiol can cause breast tenderness, water retention, and mood changes. Elevated DHT can accelerate benign prostatic hyperplasia (BPH) and male pattern hair loss. Both should be checked at the 6-week follow-up. If estradiol is elevated, a low-dose aromatase inhibitor can be added. If DHT is causing prostate symptoms, a 5-alpha reductase inhibitor may be considered. Common mistake: ignoring estradiol because it's a "female hormone" — it's a normal metabolite of testosterone and needs monitoring in men on TRT.
7. Coordinate with existing medications
Men over 50 are often on antihypertensives, statins, or metformin. TRT can affect blood pressure (slight increase in some men), lipid profiles (may shift LDL/HDL ratio), and insulin sensitivity (usually improves). A clinician should review medication interactions at baseline and at each follow-up. Blood pressure medication doses may need adjustment as TRT changes fluid balance. Common mistake: starting TRT without reviewing the full medication list for interactions.
Troubleshooting Common Setbacks
Common Setbacks
Issue, likely cause, and management approach
| Issue | Likely Cause | Action |
|---|---|---|
| Testosterone is in range but symptoms persist | SHBG may be elevated, leaving bioavailable testosterone low despite normal total; hypothyroidism becomes more common after 50 with overlapping symptoms | Check free testosterone and SHBG; evaluate thyroid function |
| PSA rose after starting TRT | A small PSA increase (0.3-0.5 ng/mL) is common in the first 3 months and is not concerning if baseline was low | A rise above 1.0 ng/mL or any PSA above 4.0 ng/mL warrants urology referral |
| Hematocrit hit 55% | TRT increases red blood cell production, which is already elevated at baseline in men over 50 | Reduce dose by 20-25% or shorten injection interval; therapeutic phlebotomy every 8-12 weeks if it doesn't improve |
| Water retention and bloating appeared | Often estradiol-related | Check estradiol levels and add a low-dose aromatase inhibitor if elevated; reducing testosterone dose slightly also helps |
| Energy improved initially but plateaued at 3 months | Levels may still be climbing, or sleep apnea (more common in men over 50) may be worsening | Check whether levels have stabilized; evaluate sleep quality |
Tools and Resources
- A clinician who understands age-specific hormone optimization, not just standard TRT protocols
- A full lab panel including free testosterone, SHBG, estradiol, PSA, and hematocrit
- A structured monitoring schedule: 6 weeks, 3 months, 6 months, then every 6-12 months
- Access to a clinician who coordinates hormone therapy with existing medications for blood pressure, cholesterol, or glucose
- Information on hormone optimization protocols at GoodLife Health
What to Do Next
If you're over 50 and experiencing fatigue, low libido, muscle loss, or mood changes, the next step is a full hormone panel — not a testosterone prescription. A direct primary care membership at GoodLife Health includes the full workup, protocol design, and ongoing monitoring.
FAQ
Is hormone optimization safe for men over 50? Yes, when properly monitored. The TRAVERSE trial (2023, n=5,198) showed no increased cardiovascular risk in men on TRT. The key safety parameters for men over 50 are hematocrit (below 54%), PSA (stable or minimally increasing), and blood pressure.
What's different about hormone optimization at 50 vs 35? SHBG is higher, free testosterone is lower for the same total, prostate monitoring is mandatory, hematocrit baseline is higher, and medication interactions are more likely. The protocol is more conservative and monitoring is more frequent.
Does TRT increase prostate cancer risk in men over 50? TRT does not initiate prostate cancer, but it can accelerate an existing cancer. This is why a PSA test and prostate exam are required before starting, and PSA is monitored at 3 and 6 months.
Can you optimize hormones without TRT? Yes, if the cause is reversible. Weight loss, sleep correction, reducing alcohol, and managing insulin resistance can each raise free testosterone meaningfully. TRT is appropriate when lifestyle factors have been addressed and levels remain low with symptoms.
How often should men over 50 get labs checked on TRT? At 6 weeks, 3 months, and 6 months after starting or changing dose. Once stable, every 6-12 months. Hematocrit and PSA are the two markers that matter most in this age group.
Does TRT affect blood pressure in men over 50? TRT can cause a slight increase in blood pressure in some men, particularly those already on antihypertensives. Blood pressure should be monitored at each follow-up, and medication adjustments may be needed.
Should men over 50 take DHEA instead of TRT? DHEA is a precursor hormone that the body converts to testosterone and estrogen. In men over 50, DHEA supplementation produces modest testosterone increases (10-20%) but is not a substitute for TRT when levels are clinically low. It may be useful as a supportive supplement alongside TRT.
What SHBG level is concerning for men over 50? SHBG above 60 nmol/L is considered elevated and will significantly reduce free testosterone even if total testosterone looks acceptable. This is increasingly common with age and with insulin resistance.
One Last Thing
The most overlooked marker in hormone optimization for men over 50 is fasting insulin. Insulin resistance raises SHBG, lowers free testosterone, and blunts the effect of TRT. A man who starts TRT with uncontrolled insulin resistance gets less symptom relief and more side effects than one who addresses the metabolic layer first. Ask for fasting insulin alongside your hormone panel — it changes the protocol.
Related Guides
References
- Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. 2018. doi.org/10.1210/jc.2018-00229